Artikel
Prognostic value of 1H-spectroscopy in untreated low-grade gliomas
Prognostischer Wert der 1H-Spektroskopie bei unbehandelten niedriggradigen Gliomen
Suche in Medline nach
Autoren
Veröffentlicht: | 30. Mai 2008 |
---|
Gliederung
Text
Objective: To evaluate the ability of proton magnetic resonance spectroscopy (1H-MRS) to predict survival time, tumor progression and malignant transformation in patients with WHO grade II gliomas.
Methods: 1H-MRS and MR imaging (MRI) were performed before surgery in 45 patients with histologically proven WHO grade II gliomas. Metabolite concentrations of choline-containing compounds (Cho) and creatine/phosphocreatine (tCr) were normalized to contralateral brain tissue. Also, intratumoral ratios of Cho/tCr and Cho/N-acetyl-aspartate were calculated. The extent of tumor resection; contrast enhancement, size and histopathological type of the tumor; age, gender and first neurological symptoms of the patients were analyzed. These parameters were analyzed for survival, tumor progression, and malignant transformation of the tumor for a follow-up period of 1 to 5 years.
Results: Positive predictors of malignant transformation of the tumor were the normalized tCr (p=0.038) and contrast enhancement of the tumor (p=0.013). The predictors with the lowest p values for tumor progression, but missing significance level, were the extent of resection and tumor size. All other parameters failed to predict the three endpoints. The normalized Cho and, with lower p value, patients’ age was an independent predictor for survival in the multivariate model (p=0.01; Hazard Ratio 5.6 for Cho).
Conclusions: The potential for malignant transformation is best indicated by the normalized tCr and tumor contrast media enhancement. Normalized Cho of the tumor tissue is an independent predictor for survival time in patients with low-grade gliomas without radio-chemotherapy. There is no reliable spectroscopic parameter to predict tumor progression during the follow-up surveillance.